Key Companies in Romania Botulism Toxin Market | Players & Insights 2026

Romania Botulism Toxin Market Overview

According to 6Wresearch, the Romania Botulism Toxin market is expected to grow steadily, owing to factors such as the growing demand for aesthetic procedures, awareness of the advantages of botulinum toxin, and increased disposable income of consumers. The market is also benefiting from the rising use of botulinum toxin in medical procedures and the availability of innovative products. These products have been popular over the years because of their non-invasive nature and their ability to cure different conditions. Additionally, their products have been widely used for aesthetic and therapeutic procedures.

Competitive Landscape

The competitive landscape of the Romania Botulism Toxin industry is influenced by a combination of established players and regional companies. The major players of the industry are utilizing their years of expertise to enhance the product quality and come up with new variants of the product. With the focus on both medical and cosmetic uses of the product, the companies are constantly motivated to innovate and increase the scope of the product to cater to the growing need of consumers. The focus on non-invasive treatments has further enhanced the competition between the major players.

Below is a list of leading players operating in the Romania Botulism Toxin Market:

1. AbbVie Inc. (Allergan)

AbbVie is a global leader, which is a widely recognized botulinum toxin brand used for aesthetic and therapeutic indications.

2. Galderma S.A.

Galderma is a major player distributing Dysport in the market for the treatment of glabellar lines and therapeutic muscle disorders.

3. Merz Pharma GmbH & Co. KGaA

Merz Aesthetics manufactures Xeomin, a purified neurotoxin without complexing proteins, which is highly utilized in aesthetic clinics.

4. Ipsen S.A.

Ipsen is a global biopharmaceutical group that manufactures Dysport, and maintain a strong presence in the medical and cosmetic segment.

5. Hugel, Inc.

Hugel is a prominent Korean company that produces Letybo, which has secured European regulatory approval for use in Romania.

6. Medytox Inc.

Medytox develops advanced botulinum toxin products and remains an active player in the European and Romanian export markets with its innovative toxin portfolio.

7. Daewoong Pharmaceutical Co., Ltd.

Daewoong produces high-purity toxin that has expanded its regulatory reach across Europe, including the Romanian aesthetic market.

8. Croma-Pharma GmbH

Croma-Pharma is a leading manufacturer that distributes botulinum toxin and premium injectables across Romania's specialized dermatology networks.

9. Evolus, Inc.

Evolus focuses exclusively on the self-pay aesthetic market, providing Nuceiva to European clinicians.

10. Revance Therapeutics, Inc.

Revance is a biotechnology company known for Daxxify, a long-lasting botulinum toxin that represents the next generation of neuromodulators.